Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial by Body, J.-J., Marin, F., Kendler, D.L., Zerbini, C.A.F., López-Romero, P., Möricke, R., Casado, E., Fahrleitner-Pammer, A., Stepan, J.J., Lespessailles, E., Minisola, S., Geusens, P.

Get full text

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group by Bilezikian, J.P., Lin, C.J.F., Brown, J.P., Wang, A.T., Yin, X., Ebeling, P.R., Fahrleitner-Pammer, A., Franek, E., Gilchrist, N., Miller, P.D., Simon, J.A., Valter, I., Zerbini, C.A.F., Libanati, C., Chines, A.

Get full text

Bone mineral density in Brazilian men 50 years and older by Zerbini, C A, Latorre, M R, Jaime, P C, Tanaka, T, Pippa, M G

Get full text

Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis by Myllykangas-Luosujärvi, R., Lu, H.S., Chen, S.L., Choon, D., Amante, C., Chow, C.T., Pasero, G., Genti, GY, Sarembock, B., Zerbini, C.A.F., Vrijens, F., Moan, A., Rodgers, D.B., Tora, L. De, Laurenzi, M.

Get full text